Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.10, 2008-10, pp. : 1473-1485

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Are Differential Behavioral Responses to Smoking and Smoking Cessation in Schizophrenia Related to Nicotinic Receptor Levels?

By Leonard S. Giordano L.

Neuropsychopharmacology, Vol. 27, Iss. 6, 2002-12 ,pp. : 1082-1083

Elsevier

Access to resources Recommend Favorite

Novel patent publications on high-affinity nicotinic acid receptor agonists

By Shen Hong C Colletti Steven L

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 7, 2009-07 ,pp. : 957-967

Informa Healthcare

Access to resources Recommend Favorite

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

By Martin Laura Kem William Freedman Robert

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 54-64

Springer Publishing Company

Access to resources Recommend Favorite

Neuronal nicotinic acetylcholine receptor agonists

By Toma Lucio Barlocco Daniela Gelain Arianna

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 7, 2004-07 ,pp. : 1029-1040

Informa Healthcare

Access to resources Recommend Favorite

Impact of Genetic Variability in Nicotinic Acetylcholine Receptors on Nicotine Addiction and Smoking Cessation Treatment

Current Medicinal Chemistry, Vol. 18, Iss. 1, 2011-01 ,pp. : 91-112

Bentham Science Publishers

Access to resources Recommend Favorite